{ "cik": 1555280, "cik_padded": "0001555280", "entityName": "Zoetis Inc.", "fiscal_years": [ { "accn": "0001555280-26-000011", "filed": "2026-02-12", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 3235000000.0, "capex": 621000000.0, "eps_diluted": 6.02, "free_cash_flow": 2283000000.0, "net_income": 2673000000.0, "operating_cash_flow": 2904000000.0, "revenue": 9467000000.0, "stockholders_equity": 3331000000.0, "total_assets": 15467000000.0, "total_liabilities": 12136000000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.6433503452416693, "net_margin": 0.2823492130558783, "revenue_growth_yoy": 0.022796024200518582, "roa_avg2y": 0.17997576084029088, "roa_period_end": 0.17281955130277363, "roe_avg2y": 0.659918528576719, "roe_period_end": 0.8024617232062444 } }, { "accn": "0001555280-26-000011", "filed": "2026-02-12", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 1858000000.0, "capex": 655000000.0, "eps_diluted": 5.47, "free_cash_flow": 2298000000.0, "net_income": 2486000000.0, "operating_cash_flow": 2953000000.0, "revenue": 9256000000.0, "stockholders_equity": 4770000000.0, "total_assets": 14237000000.0, "total_liabilities": 9467000000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.9846960167714884, "net_margin": 0.2685825410544512, "revenue_growth_yoy": 0.08333333333333333, "roa_avg2y": 0.174315464712688, "roa_period_end": 0.1746154386457821, "roe_avg2y": 0.5090611241937135, "roe_period_end": 0.5211740041928721 } }, { "accn": "0001555280-26-000011", "filed": "2026-02-12", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 1092000000.0, "capex": 732000000.0, "eps_diluted": 5.07, "free_cash_flow": 1621000000.0, "net_income": 2344000000.0, "operating_cash_flow": 2353000000.0, "revenue": 8544000000.0, "stockholders_equity": 4997000000.0, "total_assets": 14286000000.0, "total_liabilities": 9295000000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.860116069641785, "net_margin": 0.2743445692883895, "revenue_growth_yoy": 0.05742574257425743, "roa_avg2y": 0.16048748759029133, "roa_period_end": 0.16407671846563068, "roe_avg2y": 0.4986173154647947, "roe_period_end": 0.46908144886932157 } }, { "accn": "0001555280-25-000102", "filed": "2025-02-13", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 1594000000.0, "capex": 586000000.0, "eps_diluted": 4.49, "free_cash_flow": 1326000000.0, "net_income": 2114000000.0, "operating_cash_flow": 1912000000.0, "revenue": 8080000000.0, "stockholders_equity": 4405000000.0, "total_assets": 14925000000.0, "total_liabilities": 10522000000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.388649262202043, "net_margin": 0.26163366336633664, "revenue_growth_yoy": 0.03909465020576132, "roa_avg2y": 0.14667823070251518, "roa_period_end": 0.14164154103852597, "roe_avg2y": 0.4725078229772016, "roe_period_end": 0.4799091940976163 } }, { "accn": "0001555280-24-000143", "filed": "2024-02-13", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 743000000.0, "capex": 477000000.0, "eps_diluted": 4.27, "free_cash_flow": 1736000000.0, "net_income": 2037000000.0, "operating_cash_flow": 2213000000.0, "revenue": 7776000000.0, "stockholders_equity": 4543000000.0, "total_assets": 13900000000.0, "total_liabilities": 9356000000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.0594320933303982, "net_margin": 0.2619598765432099, "revenue_growth_yoy": 0.1649438202247191, "roa_avg2y": 0.1480969864408012, "roa_period_end": 0.14654676258992805, "roe_avg2y": 0.4901347449470645, "roe_period_end": 0.44838212634822805 } }, { "accn": "0001555280-23-000074", "filed": "2023-02-14", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 250000000.0, "capex": 453000000.0, "eps_diluted": 3.42, "free_cash_flow": 1673000000.0, "net_income": 1638000000.0, "operating_cash_flow": 2126000000.0, "revenue": 6675000000.0, "stockholders_equity": 3769000000.0, "total_assets": 13609000000.0, "total_liabilities": 9836000000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.609710798620324, "net_margin": 0.2453932584269663, "revenue_growth_yoy": 0.06629392971246006, "roa_avg2y": 0.13023773554901805, "roa_period_end": 0.12036152546109193, "roe_avg2y": 0.5057897174617879, "roe_period_end": 0.4345980366144866 } }, { "accn": "0001555280-22-000078", "filed": "2022-02-15", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 626000000.0, "capex": 460000000.0, "eps_diluted": 3.11, "free_cash_flow": 1335000000.0, "net_income": 1500000000.0, "operating_cash_flow": 1795000000.0, "revenue": 6260000000.0, "stockholders_equity": 2708000000.0, "total_assets": 11545000000.0, "total_liabilities": 8837000000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.2632939438700146, "net_margin": 0.23961661341853036, "revenue_growth_yoy": 0.07467811158798283, "roa_avg2y": 0.13439655944807813, "roa_period_end": 0.12992637505413598, "roe_avg2y": 0.6131207847946045, "roe_period_end": 0.5539143279172821 } }, { "accn": "0001555280-21-000098", "filed": "2021-02-16", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 698000000.0, "capex": 338000000.0, "eps_diluted": 2.93, "free_cash_flow": 1452000000.0, "net_income": 1428000000.0, "operating_cash_flow": 1790000000.0, "revenue": 5825000000.0, "stockholders_equity": 2185000000.0, "total_assets": 10777000000.0, "total_liabilities": 8592000000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.9322654462242563, "net_margin": 0.2451502145922747, "revenue_growth_yoy": 0.09760693423779913, "roa_avg2y": 0.14749780509218613, "roa_period_end": 0.13250440753456436, "roe_avg2y": 0.7221238938053097, "roe_period_end": 0.6535469107551486 } }, { "accn": "0001555280-20-000054", "filed": "2020-02-13", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 500000000.0, "capex": 224000000.0, "eps_diluted": 1.75, "free_cash_flow": 1122000000.0, "net_income": 864000000.0, "operating_cash_flow": 1346000000.0, "revenue": 5307000000.0, "stockholders_equity": 1770000000.0, "total_assets": 8586000000.0, "total_liabilities": 6800000000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.84180790960452, "net_margin": 0.1628038439796495, "revenue_growth_yoy": 0.08572013093289689, "roa_avg2y": 0.10643671080997844, "roa_period_end": 0.10062893081761008, "roe_avg2y": 0.5305495855081364, "roe_period_end": 0.48813559322033906 } }, { "accn": "0001555280-19-000041", "filed": "2019-02-14", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 300000000.0, "capex": 216000000.0, "eps_diluted": 1.65, "free_cash_flow": 497000000.0, "net_income": 821000000.0, "operating_cash_flow": 713000000.0, "revenue": 4888000000.0, "stockholders_equity": 1487000000.0, "total_assets": 7649000000.0, "total_liabilities": 6150000000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 4.135843981170141, "net_margin": 0.16796235679214402, "roa_period_end": 0.10733429206432213, "roe_period_end": 0.5521183591123067 } } ], "latest_filing": { "accn": "0001555280-26-000011", "filed": "2026-02-12", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001555280.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001555280.json" }, "ticker": "ZTS" }